Early ileal resection in Crohn's disease is not associated with severe long‐term outcomes: The ERIC study

Summary Background Early complicated Crohn's disease (CD) may require ileal resection as first‐line treatment. Aim To evaluate the long‐term outcomes of patients who underwent early ileal resection. Methods We conducted a retrospective study in two inflammatory bowel diseases (IBD) referral cen...

Full description

Saved in:
Bibliographic Details
Published inAlimentary pharmacology & therapeutics Vol. 60; no. 10; pp. 1388 - 1397
Main Authors Grellier, Nathan, Kirchgesner, Julien, Uzzan, Mathieu, Mclellan, Paul, Stefanescu, Carmen, Lefèvre, Jérémie H., Treton, Xavier, Panis, Yves, Sokol, Harry, Beaugerie, Laurent, Seksik, Philippe
Format Journal Article
LanguageEnglish
Published England Wiley Subscription Services, Inc 01.11.2024
Wiley
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Summary Background Early complicated Crohn's disease (CD) may require ileal resection as first‐line treatment. Aim To evaluate the long‐term outcomes of patients who underwent early ileal resection. Methods We conducted a retrospective study in two inflammatory bowel diseases (IBD) referral centres, including patients with ileocaecal resection and segmental ileal resection within 5 years of CD diagnosis. Early resection was defined as within 6 months of diagnosis, intermediate resection between 6 months and 2 years, and late resection between 2 and 5 years. The primary outcome was the cumulative risk of a second ileal surgery. Secondary outcomes included the use of postoperative treatments and morphological recurrence after initial surgery (Rutgeerts score ≥i2, or recurrence on imaging). Results Among 393 patients who underwent ileal resection within 5 years of diagnosis, 130, 128 and 135, respectively, had early, intermediate and late resection. The cumulative risk of second surgery at 10 years was not significantly different in the early resection group (25.0% [95% CI 17.4–35.2]), than the intermediate (16.8% [95% CI 10.5–26.2]; p = 0.17) or late resection group (22.7% [95% CI 15.1–33.3]; p = 0.83). The early resection group required fewer postoperative treatments than the late resection group with median survivals without treatments of 3.7 and 0.9 years, respectively (p = 0.002). Patients who had early resection had significantly less morphological recurrence than the late resection group (p = 0.02). Conclusion Early ileal resection in CD is not associated with a higher risk of a second resection. It may be associated with reduced use of medical treatments and fewer morphological recurrences. Early ileal resection for Crohn's disease within the first 6 months of diagnosis is not associated with a higher risk of re‐resection compared with late resection. On the contrary, patients who undergo early resection may require fewer postoperative treatments and have less evidence of disease recurrence on endoscopy and imaging.
AbstractList Early complicated Crohn's disease (CD) may require ileal resection as first-line treatment. To evaluate the long-term outcomes of patients who underwent early ileal resection. We conducted a retrospective study in two inflammatory bowel diseases (IBD) referral centres, including patients with ileocaecal resection and segmental ileal resection within 5 years of CD diagnosis. Early resection was defined as within 6 months of diagnosis, intermediate resection between 6 months and 2 years, and late resection between 2 and 5 years. The primary outcome was the cumulative risk of a second ileal surgery. Secondary outcomes included the use of postoperative treatments and morphological recurrence after initial surgery (Rutgeerts score ≥i2, or recurrence on imaging). Among 393 patients who underwent ileal resection within 5 years of diagnosis, 130, 128 and 135, respectively, had early, intermediate and late resection. The cumulative risk of second surgery at 10 years was not significantly different in the early resection group (25.0% [95% CI 17.4-35.2]), than the intermediate (16.8% [95% CI 10.5-26.2]; p = 0.17) or late resection group (22.7% [95% CI 15.1-33.3]; p = 0.83). The early resection group required fewer postoperative treatments than the late resection group with median survivals without treatments of 3.7 and 0.9 years, respectively (p = 0.002). Patients who had early resection had significantly less morphological recurrence than the late resection group (p = 0.02). Early ileal resection in CD is not associated with a higher risk of a second resection. It may be associated with reduced use of medical treatments and fewer morphological recurrences.
Summary Background Early complicated Crohn's disease (CD) may require ileal resection as first‐line treatment. Aim To evaluate the long‐term outcomes of patients who underwent early ileal resection. Methods We conducted a retrospective study in two inflammatory bowel diseases (IBD) referral centres, including patients with ileocaecal resection and segmental ileal resection within 5 years of CD diagnosis. Early resection was defined as within 6 months of diagnosis, intermediate resection between 6 months and 2 years, and late resection between 2 and 5 years. The primary outcome was the cumulative risk of a second ileal surgery. Secondary outcomes included the use of postoperative treatments and morphological recurrence after initial surgery (Rutgeerts score ≥i2, or recurrence on imaging). Results Among 393 patients who underwent ileal resection within 5 years of diagnosis, 130, 128 and 135, respectively, had early, intermediate and late resection. The cumulative risk of second surgery at 10 years was not significantly different in the early resection group (25.0% [95% CI 17.4–35.2]), than the intermediate (16.8% [95% CI 10.5–26.2]; p = 0.17) or late resection group (22.7% [95% CI 15.1–33.3]; p = 0.83). The early resection group required fewer postoperative treatments than the late resection group with median survivals without treatments of 3.7 and 0.9 years, respectively ( p = 0.002). Patients who had early resection had significantly less morphological recurrence than the late resection group ( p = 0.02). Conclusion Early ileal resection in CD is not associated with a higher risk of a second resection. It may be associated with reduced use of medical treatments and fewer morphological recurrences.
Summary Background Early complicated Crohn's disease (CD) may require ileal resection as first‐line treatment. Aim To evaluate the long‐term outcomes of patients who underwent early ileal resection. Methods We conducted a retrospective study in two inflammatory bowel diseases (IBD) referral centres, including patients with ileocaecal resection and segmental ileal resection within 5 years of CD diagnosis. Early resection was defined as within 6 months of diagnosis, intermediate resection between 6 months and 2 years, and late resection between 2 and 5 years. The primary outcome was the cumulative risk of a second ileal surgery. Secondary outcomes included the use of postoperative treatments and morphological recurrence after initial surgery (Rutgeerts score ≥i2, or recurrence on imaging). Results Among 393 patients who underwent ileal resection within 5 years of diagnosis, 130, 128 and 135, respectively, had early, intermediate and late resection. The cumulative risk of second surgery at 10 years was not significantly different in the early resection group (25.0% [95% CI 17.4–35.2]), than the intermediate (16.8% [95% CI 10.5–26.2]; p = 0.17) or late resection group (22.7% [95% CI 15.1–33.3]; p = 0.83). The early resection group required fewer postoperative treatments than the late resection group with median survivals without treatments of 3.7 and 0.9 years, respectively (p = 0.002). Patients who had early resection had significantly less morphological recurrence than the late resection group (p = 0.02). Conclusion Early ileal resection in CD is not associated with a higher risk of a second resection. It may be associated with reduced use of medical treatments and fewer morphological recurrences. Early ileal resection for Crohn's disease within the first 6 months of diagnosis is not associated with a higher risk of re‐resection compared with late resection. On the contrary, patients who undergo early resection may require fewer postoperative treatments and have less evidence of disease recurrence on endoscopy and imaging.
BackgroundEarly complicated Crohn's disease (CD) may require ileal resection as first‐line treatment.AimTo evaluate the long‐term outcomes of patients who underwent early ileal resection.MethodsWe conducted a retrospective study in two inflammatory bowel diseases (IBD) referral centres, including patients with ileocaecal resection and segmental ileal resection within 5 years of CD diagnosis. Early resection was defined as within 6 months of diagnosis, intermediate resection between 6 months and 2 years, and late resection between 2 and 5 years. The primary outcome was the cumulative risk of a second ileal surgery. Secondary outcomes included the use of postoperative treatments and morphological recurrence after initial surgery (Rutgeerts score ≥i2, or recurrence on imaging).ResultsAmong 393 patients who underwent ileal resection within 5 years of diagnosis, 130, 128 and 135, respectively, had early, intermediate and late resection. The cumulative risk of second surgery at 10 years was not significantly different in the early resection group (25.0% [95% CI 17.4–35.2]), than the intermediate (16.8% [95% CI 10.5–26.2]; p = 0.17) or late resection group (22.7% [95% CI 15.1–33.3]; p = 0.83). The early resection group required fewer postoperative treatments than the late resection group with median survivals without treatments of 3.7 and 0.9 years, respectively (p = 0.002). Patients who had early resection had significantly less morphological recurrence than the late resection group (p = 0.02).ConclusionEarly ileal resection in CD is not associated with a higher risk of a second resection. It may be associated with reduced use of medical treatments and fewer morphological recurrences.
Background: Early complicated Crohn's disease (CD) may require ileal resection as first-line treatment.Aim: To evaluate the long-term outcomes of patients who underwent early ilealresection.Methods: We conducted a retrospective study in two inflammatory bowel diseases (IBD) referral centres, including patients with ileocaecal resection and segmental ileal resection within 5 years of CD diagnosis. Early resection was defined as within 6 months of diagnosis, intermediate resection between 6 months and 2 years, and late resection between 2 and 5 years. The primary outcome was the cumulative risk of a second ileal surgery. Secondary outcomes included the use of postoperative treatments and morphological recurrence after initial surgery (Rutgeerts score ≥i2, or re-currence on imaging).Results: Among 393 patients who underwent ileal resection within 5 years of diagnosis, 130, 128 and 135, respectively, had early, intermediate and late resection. The cumulative risk of second surgery at 10 years was not significantly different in the early resection group (25.0% [95% CI 17.4–35.2]), than the intermediate (16.8% [95%CI 10.5–26.2]; p = 0.17) or late resection group (22.7% [95% CI 15.1–33.3]; p = 0.83). The early resection group required fewer postoperative treatments than the late resection group with median survivals without treatments of 3.7 and 0.9 years, respectively (p = 0.002). Patients who had early resection had significantly less morphological recurrence than the late resection group (p = 0.02).Conclusion: Early ileal resection in CD is not associated with a higher risk of a second resection. It may be associated with reduced use of medical treatments and fewer morphological recurrences.
Early complicated Crohn's disease (CD) may require ileal resection as first-line treatment.BACKGROUNDEarly complicated Crohn's disease (CD) may require ileal resection as first-line treatment.To evaluate the long-term outcomes of patients who underwent early ileal resection.AIMTo evaluate the long-term outcomes of patients who underwent early ileal resection.We conducted a retrospective study in two inflammatory bowel diseases (IBD) referral centres, including patients with ileocaecal resection and segmental ileal resection within 5 years of CD diagnosis. Early resection was defined as within 6 months of diagnosis, intermediate resection between 6 months and 2 years, and late resection between 2 and 5 years. The primary outcome was the cumulative risk of a second ileal surgery. Secondary outcomes included the use of postoperative treatments and morphological recurrence after initial surgery (Rutgeerts score ≥i2, or recurrence on imaging).METHODSWe conducted a retrospective study in two inflammatory bowel diseases (IBD) referral centres, including patients with ileocaecal resection and segmental ileal resection within 5 years of CD diagnosis. Early resection was defined as within 6 months of diagnosis, intermediate resection between 6 months and 2 years, and late resection between 2 and 5 years. The primary outcome was the cumulative risk of a second ileal surgery. Secondary outcomes included the use of postoperative treatments and morphological recurrence after initial surgery (Rutgeerts score ≥i2, or recurrence on imaging).Among 393 patients who underwent ileal resection within 5 years of diagnosis, 130, 128 and 135, respectively, had early, intermediate and late resection. The cumulative risk of second surgery at 10 years was not significantly different in the early resection group (25.0% [95% CI 17.4-35.2]), than the intermediate (16.8% [95% CI 10.5-26.2]; p = 0.17) or late resection group (22.7% [95% CI 15.1-33.3]; p = 0.83). The early resection group required fewer postoperative treatments than the late resection group with median survivals without treatments of 3.7 and 0.9 years, respectively (p = 0.002). Patients who had early resection had significantly less morphological recurrence than the late resection group (p = 0.02).RESULTSAmong 393 patients who underwent ileal resection within 5 years of diagnosis, 130, 128 and 135, respectively, had early, intermediate and late resection. The cumulative risk of second surgery at 10 years was not significantly different in the early resection group (25.0% [95% CI 17.4-35.2]), than the intermediate (16.8% [95% CI 10.5-26.2]; p = 0.17) or late resection group (22.7% [95% CI 15.1-33.3]; p = 0.83). The early resection group required fewer postoperative treatments than the late resection group with median survivals without treatments of 3.7 and 0.9 years, respectively (p = 0.002). Patients who had early resection had significantly less morphological recurrence than the late resection group (p = 0.02).Early ileal resection in CD is not associated with a higher risk of a second resection. It may be associated with reduced use of medical treatments and fewer morphological recurrences.CONCLUSIONEarly ileal resection in CD is not associated with a higher risk of a second resection. It may be associated with reduced use of medical treatments and fewer morphological recurrences.
Author Lefèvre, Jérémie H.
Treton, Xavier
Beaugerie, Laurent
Grellier, Nathan
Sokol, Harry
Stefanescu, Carmen
Seksik, Philippe
Panis, Yves
Kirchgesner, Julien
Uzzan, Mathieu
Mclellan, Paul
Author_xml – sequence: 1
  givenname: Nathan
  orcidid: 0000-0002-0452-3218
  surname: Grellier
  fullname: Grellier, Nathan
  organization: Sorbonne Université, INSERM, APHP, Hôpital Saint‐Antoine
– sequence: 2
  givenname: Julien
  orcidid: 0000-0002-2314-9284
  surname: Kirchgesner
  fullname: Kirchgesner, Julien
  organization: Sorbonne Université, INSERM, APHP, Hôpital Saint‐Antoine
– sequence: 3
  givenname: Mathieu
  surname: Uzzan
  fullname: Uzzan, Mathieu
  organization: Mondor Hospital
– sequence: 4
  givenname: Paul
  surname: Mclellan
  fullname: Mclellan, Paul
  organization: Sorbonne Université, INSERM, APHP, Hôpital Saint‐Antoine
– sequence: 5
  givenname: Carmen
  surname: Stefanescu
  fullname: Stefanescu, Carmen
  organization: Paris IBD Center, Groupe Hospitalier Privé Ambroise Pare‐Hartmann
– sequence: 6
  givenname: Jérémie H.
  surname: Lefèvre
  fullname: Lefèvre, Jérémie H.
  organization: Saint‐Antoine Hospital
– sequence: 7
  givenname: Xavier
  surname: Treton
  fullname: Treton, Xavier
  organization: Paris IBD Center, Groupe Hospitalier Privé Ambroise Pare‐Hartmann
– sequence: 8
  givenname: Yves
  surname: Panis
  fullname: Panis, Yves
  organization: Paris IBD Center, Groupe Hospitalier Privé Ambroise Pare‐Hartmann
– sequence: 9
  givenname: Harry
  orcidid: 0000-0002-2914-1822
  surname: Sokol
  fullname: Sokol, Harry
  organization: Sorbonne Université, INSERM, APHP, Hôpital Saint‐Antoine
– sequence: 10
  givenname: Laurent
  surname: Beaugerie
  fullname: Beaugerie, Laurent
  organization: Sorbonne Université, INSERM, APHP, Hôpital Saint‐Antoine
– sequence: 12
  givenname: Philippe
  orcidid: 0000-0003-3596-9893
  surname: Seksik
  fullname: Seksik, Philippe
  email: philippe.seksik@aphp.fr
  organization: Sorbonne Université, INSERM, APHP, Hôpital Saint‐Antoine
BackLink https://www.ncbi.nlm.nih.gov/pubmed/39234950$$D View this record in MEDLINE/PubMed
https://hal.science/hal-04691632$$DView record in HAL
BookMark eNp1kcFq3DAQhkVJaDZpDn2BIuih6cHJSLItubdl2TaBhZayOQtZHneV2tZWkhP2lkfoM_ZJ6mTTFAqdy8Dw8c8M3zE5GPyAhLxmcM6mujDbdM4Uz-ULMmOiLDIOojwgM-BllXHFxBE5jvEGAEoJ_CU5EhUXeVXAjHxfmtDtqOvQdDRgRJucH6gb6CL4zfAu0sZFNBGpi3TwiZoYvXUmYUPvXNrQiLcYkHZ--Pbr_mfC0FM_Jut7jB_oeoN0-fVqQWMam90rctiaLuLpUz8h1x-X68Vltvr86WoxX2VWMC4z0ygAZatCWZZLK8EWBpVStW0ApBK2kHXJS1EDUzIvjMzztmZNi6bBVplWnJD3-9yN6fQ2uN6EnfbG6cv5Sj_MIC8rVgp-yyb2bM9ug_8xYky6d9Fi15kB_Ri1YAAVU0rkE_r2H_TGj2GYPpkoVknBS4C_y23wMQZsny9goB9s6cmWfrQ1sW-eEse6x-aZ_KNnAi72wN0kaPf_JD3_st5H_gbwLJ-G
Cites_doi 10.1016/0016-5085(90)90613-6
10.1016/S2468-1253(20)30117-5
10.1111/codi.15813
10.1136/gutjnl-2017-315568
10.1093/ecco-jcc/jjy113
10.3390/jcm10040731
10.1016/S0140-6736(17)32448-0
10.1016/j.cgh.2021.06.035
10.1097/MEG.0000000000001206
10.1016/j.dld.2022.09.016
10.1007/s00384-018-2995-9
10.1016/j.cgh.2019.12.036
10.1016/j.crohns.2009.09.009
10.1093/bjsopen/zrad097
10.1111/j.1365-2036.2007.03515.x
10.1136/gutjnl-2018-317539
10.1038/ajg.2012.298
10.1007/s00330-008-1034-6
10.1053/j.gastro.2011.01.055
10.1016/S0140-6736(16)31711-1
10.1016/S2468-1253(17)30248-0
10.1053/j.gastro.2023.05.051
ContentType Journal Article
Copyright 2024 The Author(s). published by John Wiley & Sons Ltd.
2024 The Author(s). Alimentary Pharmacology & Therapeutics published by John Wiley & Sons Ltd.
2024. This article is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Attribution - NoDerivatives
Copyright_xml – notice: 2024 The Author(s). published by John Wiley & Sons Ltd.
– notice: 2024 The Author(s). Alimentary Pharmacology & Therapeutics published by John Wiley & Sons Ltd.
– notice: 2024. This article is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: Attribution - NoDerivatives
CorporateAuthor ERIC Study group
the ERIC Study group
CorporateAuthor_xml – name: ERIC Study group
– name: the ERIC Study group
DBID 24P
WIN
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7T5
7TK
7U9
H94
M7N
7X8
1XC
VOOES
DOI 10.1111/apt.18247
DatabaseName Wiley-Blackwell Open Access Collection
Wiley Online Library Journals
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
Immunology Abstracts
Neurosciences Abstracts
Virology and AIDS Abstracts
AIDS and Cancer Research Abstracts
Algology Mycology and Protozoology Abstracts (Microbiology C)
MEDLINE - Academic
Hyper Article en Ligne (HAL)
Hyper Article en Ligne (HAL) (Open Access)
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
AIDS and Cancer Research Abstracts
Immunology Abstracts
Virology and AIDS Abstracts
Neurosciences Abstracts
Algology Mycology and Protozoology Abstracts (Microbiology C)
MEDLINE - Academic
DatabaseTitleList MEDLINE
CrossRef

AIDS and Cancer Research Abstracts

MEDLINE - Academic
Database_xml – sequence: 1
  dbid: 24P
  name: Wiley Open Access
  url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html
  sourceTypes: Publisher
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1365-2036
EndPage 1397
ExternalDocumentID oai_HAL_hal_04691632v1
10_1111_apt_18247
39234950
APT18247
Genre researchArticle
Multicenter Study
Journal Article
GroupedDBID ---
.3N
.GA
.GJ
.Y3
05W
0R~
10A
1OB
1OC
23M
24P
31~
33P
36B
3SF
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5HH
5LA
5VS
66C
6J9
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AAKAS
AANLZ
AAONW
AASGY
AAXRX
AAZKR
ABCQN
ABCUV
ABDBF
ABEML
ABJNI
ABOCM
ABPVW
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFS
ACGOF
ACMXC
ACPOU
ACPRK
ACSCC
ACXBN
ACXQS
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADOZA
ADXAS
ADZCM
ADZMN
ADZOD
AEEZP
AEGXH
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFEBI
AFFPM
AFGKR
AFPWT
AFRAH
AFZJQ
AHBTC
AHEFC
AIACR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMBMR
AMYDB
ASPBG
ATUGU
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BAWUL
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CAG
COF
D-6
D-7
D-E
D-F
DC6
DCZOG
DIK
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DTERQ
E3Z
EAD
EAP
EAS
EBC
EBD
EBS
EBX
EJD
EMB
EMK
EMOBN
EST
ESX
EX3
F00
F01
F04
F5P
FEDTE
FIJ
FUBAC
FZ0
G-S
G.N
GODZA
GX1
H.X
HF~
HGLYW
HVGLF
HZI
HZ~
IHE
IPNFZ
IX1
J0M
K48
KBYEO
LATKE
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MK0
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
O66
O9-
OIG
OK1
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
P6G
PALCI
Q.N
Q11
QB0
Q~Q
R.K
RIWAO
RJQFR
ROL
RX1
SAMSI
SUPJJ
SV3
TEORI
TR2
TUS
UB1
V8K
V9Y
W8V
W99
WBKPD
WH7
WHWMO
WIH
WIJ
WIK
WIN
WOHZO
WOW
WQJ
WRC
WUP
WVDHM
WXI
WXSBR
XG1
YOC
ZZTAW
~IA
~WT
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7T5
7TK
7U9
H94
M7N
7X8
1XC
VOOES
ID FETCH-LOGICAL-c3127-ad8008c958c147c70c5ae888bcd00783c57b6263b018745a744fb1dfeadef8af3
IEDL.DBID DR2
ISSN 0269-2813
1365-2036
IngestDate Sat Nov 09 06:43:34 EST 2024
Thu Oct 24 16:46:21 EDT 2024
Thu Oct 24 14:31:10 EDT 2024
Wed Oct 30 12:26:57 EDT 2024
Sat Nov 02 12:18:47 EDT 2024
Thu Oct 24 09:52:40 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 10
Keywords Crohn 's disease
Surgery
IBD
Language English
License Attribution-NonCommercial-NoDerivs
2024 The Author(s). Alimentary Pharmacology & Therapeutics published by John Wiley & Sons Ltd.
Attribution - NoDerivatives: http://creativecommons.org/licenses/by-nd
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c3127-ad8008c958c147c70c5ae888bcd00783c57b6263b018745a744fb1dfeadef8af3
Notes The Handling Editor for this article was Professor Richard Gearry, and it was accepted for publication after full peer‐review.
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0003-3596-9893
0000-0002-0452-3218
0000-0002-2914-1822
0000-0002-2314-9284
OpenAccessLink https://proxy.k.utb.cz/login?url=https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fapt.18247
PMID 39234950
PQID 3119732600
PQPubID 2045200
PageCount 10
ParticipantIDs hal_primary_oai_HAL_hal_04691632v1
proquest_miscellaneous_3100918834
proquest_journals_3119732600
crossref_primary_10_1111_apt_18247
pubmed_primary_39234950
wiley_primary_10_1111_apt_18247_APT18247
PublicationCentury 2000
PublicationDate November 2024
PublicationDateYYYYMMDD 2024-11-01
PublicationDate_xml – month: 11
  year: 2024
  text: November 2024
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
– name: Chichester
PublicationTitle Alimentary pharmacology & therapeutics
PublicationTitleAlternate Aliment Pharmacol Ther
PublicationYear 2024
Publisher Wiley Subscription Services, Inc
Wiley
Publisher_xml – name: Wiley Subscription Services, Inc
– name: Wiley
References 2020; 5
2021; 10
1990; 99
2017; 2
2021; 23
2023; 55
2023; 7
2019; 68
2019; 13
2008; 18
2023; 165
2021; 19
2017; 390
2018; 30
2022; 20
2011; 140
2018; 33
2017; 389
2010; 4
2012; 107
2007; 26
e_1_2_10_12_1
e_1_2_10_23_1
e_1_2_10_9_1
e_1_2_10_13_1
e_1_2_10_10_1
e_1_2_10_21_1
e_1_2_10_11_1
e_1_2_10_22_1
e_1_2_10_20_1
e_1_2_10_2_1
e_1_2_10_4_1
e_1_2_10_18_1
e_1_2_10_3_1
e_1_2_10_19_1
e_1_2_10_6_1
e_1_2_10_16_1
e_1_2_10_5_1
e_1_2_10_17_1
e_1_2_10_8_1
e_1_2_10_14_1
e_1_2_10_7_1
e_1_2_10_15_1
References_xml – volume: 99
  start-page: 956
  year: 1990
  end-page: 963
  article-title: Predictability of the postoperative course of Crohn's disease
  publication-title: Gastroenterology
– volume: 7
  year: 2023
  article-title: Impact of timing of primary ileocecal resection on prognosis in patients with Crohn's disease
  publication-title: BJS Open
– volume: 10
  start-page: 731
  year: 2021
  article-title: Early ileocecal resection is an effective therapy in isolated Crohn's disease
  publication-title: J Clin Med
– volume: 20
  start-page: e1040
  year: 2022
  end-page: e1049
  article-title: A magnetic resonance imaging index to predict Crohn's disease postoperative recurrence: the MONITOR index
  publication-title: Clin Gastroenterol Hepatol
– volume: 5
  start-page: 900
  year: 2020
  end-page: 907
  article-title: Laparoscopic ileocaecal resection versus infliximab for terminal ileitis in Crohn's disease: retrospective long‐term follow‐up of the LIR!C trial
  publication-title: Lancet Gastroenterol Hepatol
– volume: 107
  start-page: 1693
  year: 2012
  end-page: 1701
  article-title: Surgery in a population‐based cohort of Crohn's disease from Olmsted County, Minnesota (1970‐2004)
  publication-title: Am J Gastroenterol
– volume: 389
  start-page: 1741
  year: 2017
  end-page: 1755
  article-title: Crohn's disease
  publication-title: Lancet
– volume: 26
  start-page: 1303
  year: 2007
  end-page: 1312
  article-title: Early versus late surgery for ileo‐caecal Crohn's disease
  publication-title: Aliment Pharmacol Ther
– volume: 68
  start-page: 423
  year: 2019
  end-page: 433
  article-title: Natural disease course of Crohn's disease during the first 5 years after diagnosis in a European population‐based inception cohort: an Epi‐IBD study
  publication-title: Gut
– volume: 4
  start-page: 63
  year: 2010
  end-page: 101
  article-title: The second European evidence‐based consensus on the diagnosis and management of Crohn's disease: special situations
  publication-title: J Crohns Colitis
– volume: 18
  start-page: 2512
  year: 2008
  end-page: 2521
  article-title: Anastomotic recurrence of Crohn's disease after ileocolic resection: comparison of MR enteroclysis with endoscopy
  publication-title: Eur Radiol
– volume: 23
  start-page: 2690
  year: 2021
  end-page: 2698
  article-title: Patients' perceptions of surgery for inflammatory bowel disease
  publication-title: Color Dis
– volume: 2
  start-page: 785
  year: 2017
  end-page: 792
  article-title: Laparoscopic ileocaecal resection versus infliximab for terminal ileitis in Crohn's disease: a randomised controlled, open‐label, multicentre trial
  publication-title: Lancet Gastroenterol Hepatol
– volume: 13
  start-page: 144
  year: 2019
  end-page: 164K
  article-title: ECCO‐ESGAR Guideline for Diagnostic Assessment in IBD part 1: initial diagnosis, monitoring of known IBD, detection of complications
  publication-title: J Crohn's Colitis
– volume: 33
  start-page: 473
  year: 2018
  end-page: 477
  article-title: Surgical recurrence in Crohn's disease: a comparison between different types of bowel resections
  publication-title: Int J Color Dis
– volume: 68
  start-page: 1774
  year: 2019
  end-page: 1780
  article-title: Cost‐effectiveness of laparoscopic ileocaecal resection versus infliximab treatment of terminal ileitis in Crohn's disease: the LIR!C trial
  publication-title: Gut
– volume: 30
  start-page: 1143
  year: 2018
  end-page: 1147
  article-title: Risk factors for anastomotic recurrence after primary ileocaecal resection in Crohn's disease
  publication-title: Eur J Gastroenterol Hepatol
– volume: 140
  start-page: 1785
  year: 2011
  end-page: 1794
  article-title: Epidemiology and natural history of inflammatory bowel diseases
  publication-title: Gastroenterology
– volume: 165
  start-page: 976
  issue: 4
  year: 2023
  end-page: 985
  article-title: Early ileocecal resection for Crohn's disease is associated with improved long‐term outcomes compared to anti‐tumor necrosis factor therapy: a population‐based cohort study
  publication-title: Gastroenterology
– volume: 55
  start-page: 872
  year: 2023
  end-page: 879
  article-title: Disease course and treatment outcomes of Crohn's disease patients with early or late surgery—a Danish nationwide cohort study from 1997 to 2015
  publication-title: Dig Liver Dis
– volume: 390
  start-page: 2769
  year: 2017
  end-page: 2778
  article-title: Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population‐based studies
  publication-title: Lancet
– volume: 19
  start-page: 1602
  year: 2021
  end-page: 1610.e1
  article-title: A scoring system to determine Patients' risk of colectomy within 1 year after hospital admission for acute severe ulcerative colitis
  publication-title: Clin Gastroenterol Hepatol
– ident: e_1_2_10_16_1
  doi: 10.1016/0016-5085(90)90613-6
– ident: e_1_2_10_8_1
  doi: 10.1016/S2468-1253(20)30117-5
– ident: e_1_2_10_6_1
  doi: 10.1111/codi.15813
– ident: e_1_2_10_4_1
  doi: 10.1136/gutjnl-2017-315568
– ident: e_1_2_10_18_1
  doi: 10.1093/ecco-jcc/jjy113
– ident: e_1_2_10_11_1
  doi: 10.3390/jcm10040731
– ident: e_1_2_10_2_1
  doi: 10.1016/S0140-6736(17)32448-0
– ident: e_1_2_10_20_1
  doi: 10.1016/j.cgh.2021.06.035
– ident: e_1_2_10_22_1
  doi: 10.1097/MEG.0000000000001206
– ident: e_1_2_10_13_1
  doi: 10.1016/j.dld.2022.09.016
– ident: e_1_2_10_23_1
  doi: 10.1007/s00384-018-2995-9
– ident: e_1_2_10_15_1
  doi: 10.1016/j.cgh.2019.12.036
– ident: e_1_2_10_17_1
  doi: 10.1016/j.crohns.2009.09.009
– ident: e_1_2_10_21_1
  doi: 10.1093/bjsopen/zrad097
– ident: e_1_2_10_12_1
  doi: 10.1111/j.1365-2036.2007.03515.x
– ident: e_1_2_10_9_1
  doi: 10.1136/gutjnl-2018-317539
– ident: e_1_2_10_14_1
  doi: 10.1038/ajg.2012.298
– ident: e_1_2_10_19_1
  doi: 10.1007/s00330-008-1034-6
– ident: e_1_2_10_5_1
  doi: 10.1053/j.gastro.2011.01.055
– ident: e_1_2_10_3_1
  doi: 10.1016/S0140-6736(16)31711-1
– ident: e_1_2_10_7_1
  doi: 10.1016/S2468-1253(17)30248-0
– ident: e_1_2_10_10_1
  doi: 10.1053/j.gastro.2023.05.051
SSID ssj0006702
Score 2.506579
Snippet Summary Background Early complicated Crohn's disease (CD) may require ileal resection as first‐line treatment. Aim To evaluate the long‐term outcomes of...
Early complicated Crohn's disease (CD) may require ileal resection as first-line treatment. To evaluate the long-term outcomes of patients who underwent early...
Summary Background Early complicated Crohn's disease (CD) may require ileal resection as first‐line treatment. Aim To evaluate the long‐term outcomes of...
BackgroundEarly complicated Crohn's disease (CD) may require ileal resection as first‐line treatment.AimTo evaluate the long‐term outcomes of patients who...
Early complicated Crohn's disease (CD) may require ileal resection as first-line treatment.BACKGROUNDEarly complicated Crohn's disease (CD) may require ileal...
Background: Early complicated Crohn's disease (CD) may require ileal resection as first-line treatment.Aim: To evaluate the long-term outcomes of patients who...
SourceID hal
proquest
crossref
pubmed
wiley
SourceType Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage 1388
SubjectTerms Adult
Crohn Disease - surgery
Crohn's disease
Crohns disease
Diagnosis
Female
Human health and pathology
Humans
Hépatology and Gastroenterology
Ileum - pathology
Ileum - surgery
Inflammatory bowel diseases
Life Sciences
Male
Medical treatment
Middle Aged
Morphology
Patients
Recurrence
Reoperation - statistics & numerical data
Retrospective Studies
Surgery
Time Factors
Treatment Outcome
Young Adult
Title Early ileal resection in Crohn's disease is not associated with severe long‐term outcomes: The ERIC study
URI https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fapt.18247
https://www.ncbi.nlm.nih.gov/pubmed/39234950
https://www.proquest.com/docview/3119732600
https://www.proquest.com/docview/3100918834
https://hal.science/hal-04691632
Volume 60
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB61PSAuvB8LbWUQElyy2thO7NLTqlCtEEUVaqUekCLbsWlVlFSbLAdO_IT-xv4SZpwHFISEuEXJ2HE8nvgbe-YzwAvEwFypUiUz7lQijc0TK7VJRFaGXPtUqEBLAwcf8sWxfHeSnazB7pAL0_FDjAtuZBnxf00Gbmzzi5Gbi3aK4FhSJjlWSeFcbz7-pI7KVYw3RBdjJ-E6FT2rEEXxjCWvzUXrpxQJ-SfMvI5a47Szfxs-DQ3uok3Op6vWTt2337gc__OL7sCtHo6yeTd-7sKar-7BjYN-w_0-nEcCZIbVoRRlKsU0CHZWsb1lfVq9bFi_w8POGlbVLTO9un3JaImX4cTrl559qavPV98vaR5g9arFlvnmNcMxyiiilUWS2wdwvP_2aG-R9OczJE6kXCWmRLSp3U6mXSqVUzOXGY8etXUlIQ_hMmWJ7MbGg_8yo6QMNi0DxWgHbYJ4CBtVXfnHwKQXOnA_cwohhZihux-4S62wCJB0yPkEng-aKi46Go5icF-w24rYbSiEOhyfE3H2Yv6-oHu0CoDIk39NJ7A5qLjozbUpBG2mCuLqn8Cz8TEaGu2emMrXK5JBOJpqLeQEHnVDY3wVgkyBniaWfhUV_Pc2FvPDo3jx5N9Fn8JNjlCqy4DchI12ufJbCIVauw3rXB5ux5H_A_h9A9I
link.rule.ids 230,315,783,787,888,1378,11574,27936,27937,46064,46306,46488,46730
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3NatwwEB7yA20vJenvtmmjlkJzcVlLsqWUXJbQsGl3Qw4byM1IstQNLXbY9facR8gz9kk6I3tNQwn0ZqwRNjMazTfS6BPAB8TAXKlSJUPuVCKNzRMrtUlEVoZc-1SoQEsD07N8fCG_XmaXG3C0PgvT8kP0C27kGXG-JgenBem_vNxcN58QHUu1Cdsyx4FIvM7yvJ-HcxUrDjHJOEy4TkXHK0R1PH3XO9Foc061kP8Czbu4NQaekx143CFGNmpNvAsbvnoCD6bdnvhT-BE5ihl2RSk6TBRPKrCrih0v6nn1ccm6TRh2tWRV3TDTWcSXjFZhGcZGv_DsZ119_31zS1M1q1cNqsMvPzMcRoyKTlnkoX0GFydfZsfjpLtCIXEi5SoxJQJC7Q4z7VKpnBq6zHhMeq0rCRwIlylLfDQ23s2XGSVlsGkZqIw6aBPEc9iq6sq_BCa90IH7oVMY9cUQM_LAXWqFRQyjQ84H8H6tyuK6Zcoo1hkG6ruI-kYhVHLfTtzW49GkoHeUqCM45L_SAeytbVB0HrUsBO13CqLTH8C7vhl9gTY4TOXrFckgYky1FnIAL1rb9Z9CHCgwGcTeB9GY9_9jMTqfxYdX_y-6Dw_Hs-mkmJyefXsNjzgin_bA4h5sNYuVf4PIpbFv4wD9A2mY5k0
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NbtQwEB61Raq4lH-6pYBBSHDJamM7sQunVctqgbaqUCv1gBTFjk2rVslqN8uBE4_AM_IkzDg_pSAkxC2K7cTxzMTf2DOfAV4gBuZKFSoacasimZs0MlLnkUgKn2oXC-VpaeDgMJ2eyPenyekKvOlyYRp-iH7BjSwj_K_JwGeF_8XI81k9RHAs1SrckCkiX0JEH6-4o1IVAg7Rx9iJuI5FSytEYTx902uT0eoZhUL-iTOvw9Yw70xuwaeux024ycVwWZuh_fobmeN_ftJt2GjxKBs3CnQHVlx5F9YP2h33e3ARGJAZPg5rUapSyINg5yXbnVdn5csFa7d42PmClVXN8lbermC0xstw5nVzxy6r8vOPb99pImDVssaeucVrhkrKKKSVBZbb-3AyeXu8O43aAxoiK2KuorxAuKntTqJtLJVVI5vkDl1qYwuCHsImyhDbjQkn_yW5ktKbuPAUpO117sUDWCur0m0Ck05oz93IKsQUYoT-vuc2NsIgQtI-5QN43kkqmzU8HFnnv-CwZWHYsBLKsC8n5uzpeD-je7QMgNCTf4kHsN2JOGvtdZEJ2k0VRNY_gGd9MVoabZ_kpauWVAfxaKy1kAN42KhG_ypEmQJdTWz9Kgj4733MxkfH4WLr36s-hfWjvUm2_-7wwyO4yRFWNdmQ27BWz5fuMcKi2jwJ6v8T6jIFwg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Early+ileal+resection+in+Crohn%27s+disease+is+not+associated+with+severe+long-term+outcomes%3A+The+ERIC+study&rft.jtitle=Alimentary+pharmacology+%26+therapeutics&rft.au=Grellier%2C+Nathan&rft.au=Kirchgesner%2C+Julien&rft.au=Uzzan%2C+Mathieu&rft.au=Mclellan%2C+Paul&rft.date=2024-11-01&rft.eissn=1365-2036&rft.volume=60&rft.issue=10&rft.spage=1388&rft_id=info:doi/10.1111%2Fapt.18247&rft_id=info%3Apmid%2F39234950&rft.externalDocID=39234950
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0269-2813&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0269-2813&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0269-2813&client=summon